DealMaker's Technology Powers Over $1 Billion In Online Capital Raises

January 5, 2022

The technology platform shares highlights from 2021 and looks ahead to 2022

2021 was a record breaking year for DealMaker, the market-leading technology platform behind online capital raising transactions. DealMaker powered a number of landmark transactions, including Carbon Streaming’s $104.9M Private Placement, the largest ever non-brokered online private placement, and the Green Bay Packers’ 2021 Common Stock Offering, the sixth historic offering in the organization’s history that saw over $30M raised within the first 48 hours. Growth in the retail capital markets drove increasing numbers of sophisticated issuers to pursue retail financings, and the DealMaker team is looking forward to another incredible year in 2022 as retail capital raising continues to break new records.

Additional highlights from 2021 include:

Crossing the $1 billion mark in total capital raised via DealMaker, double the volume of other online capital raising platforms.
Servicing over 400 issuers since our inception. In 2021, issuers came from a wide variety of industries, with healthtech, renewable energy, and robotics shining as key verticals.
An average investment ticket of over $2,600 on retail capital raises (Reg A/CF), reinforcing the commitment to (and powerful technological superiority toward) powering increased investor conversion.
Over 400,000 investor profiles created to date with highest conversion rates coming from Switzerland, Canada, Singapore and the Netherlands.
Powering one of the first over-subscribed $5M Reg CF offerings, Trust Stamp.

Issuers using DealMaker pushed the boundaries of speed and scale in the capital markets, as our technology allowed them to reach previously unimaginable opportunities.

DealMaker powered three issuers raising over $30M in less than 48 hours. Congratulations to Carbon Streaming Corp, Osisko Development Corp, and the Green Bay Packers!
DealMaker powered 10 issuers raising over $20M, with some continuing to raise. Congratulations to our issuers setting a new standard for success in retail offerings.

As leading issuers continue to select and highlight DealMaker as the premier technology solution to power their capital raises, DealMaker itself is proud to have grown alongside the market, expanding its team, solutions, and corporate initiatives. 2021 company milestones include:

Launching DealMaker Shareholder Services, a significant technology for US-registered Transfer Agent services, based in Tampa, Florida.
Increasing headcount from 16 to 60+ talented and dedicated full time employees, across 3 continents.
Growing our product offerings by over 300% including new technology solutions for shareholder management and communications, advanced analytics and digital marketing integrations, cryptocurrency payments, a patent-pending investor scoring algorithm, and more.
Growing network of active partners to over 160 firms.
Main stage features at landmark events including Money2020, Equity Crowdfunding Week, the 2021 Angels and Entrepreneurs Retreat, and more.
Hosting a multi-part webinar series covering cutting-edge topics in capital markets innovation from Digital Warrant Exercise to Tokenization of Securities, featuring expert guests including US Congressman Warren Davidson.

Ready to hit the ground running in 2022, DealMaker shows no signs of halting its breakneck pace of over 600% year over year growth with over $1.5B in its offering pipeline. Issuers and service providers in the capital markets should reach out via www.dealmaker.tech to connect with a representative, and follow company updates via DealMaker’s mailing list and LinkedIn page.

News Links:

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date	End Date	Type	Platform	Amount Raised	# Investors
3/13/19	3/31/20	A+	SeedInvest	$14,588,668	6,000
11/16/20	1/16/21	A+	StartEngine	$2,965,501	8,000
1/17/21	2/18/22	A+	StartEngine	$23,647,853	14,082
7/15/22	3/16/23	CF	DealMaker	$4,673,000	2,249
3/1/23	4/8/23	A+	Republic	$232,275	120
3/1/23	5/23/23	A+	DealMaker	$15,958,364	5,198
5/18/23	-	Nasdaq listing
7/24	10/24	Unit Offering	DealMaker	$12,990,103	2,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+

Raised across seven campaigns

~40,000

Investors championing Monogram's vision

20%

Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

Filed its first patent application in 2017
Conducted clinical studies at UCLA and University of Nebraska
Expanded the team with key hires
Attracted a top-tier advisory board to guide clinical innovations
Signed their first distribution partnerships
Made headlines with cutting-edge live demonstrations
Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

Go from concept to commercialization without relying on VCs
Retain ownership and control in a high-burn industry
Build a base of loyal shareholders who invested not once, but over and over again
Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker